Synopsis of recent research by authors named "Yeon-Yong Cho"
- Yeon-Yong Cho's research primarily focuses on the role of receptor tyrosine kinases (RTK) in mammary cancer and the therapeutic potential of RTK inhibitors.
- One of the key findings from his work is that the small molecule dual RTK inhibitor lapatinib effectively suppresses RTK-mediated signaling, which is crucial for mammary cancer prognosis.
- The research emphasizes the importance of identifying specific protein targets affected by lapatinib and other RTK inhibitors to understand the variability in their preventive efficacy against cancer.
